Abstract
Sodium iodide symporter (NIS) is a molecule involved in active accumulation of iodine in thyroid gland for the biosynthesis of thyroid hormone. Its expression has also been demonstrated in extra-thyroidal tissues including lactating mice mammary gland and also in human breast cancers. Iodide transport in thyroid cells through NIS is the basis for using radioiodine for diagnosis and treatment of differentiated thyroid carcinoma. The similar approach may prove beneficial for the diagnosis and treatment of breast cancer if iodine uptake, its retention and NIS expression can be shown unequivocally in malignant tumors. The aim of the present study was to investigate NIS expression, in vivo iodine transport ability and fate of iodine in human breast tumors. Women (age 33–58 years) with infiltrating duct carcinoma confirmed by FNAC and subsequent histopathology were the subject of this study. Expression of NIS RNA and protein was confirmed by RNAase protection assay, western blot and immunohistochemistry respectively in surgically excised breast tumor tissue. Iodine transport ability and its nature was assessed both in vivo and in vitro. We report high NIS expression at both transcriptional and translational level and its ability to transport iodine in human breast tumors. The in vivo iodine transport ability was confirmed by scintigraphy. Unlike thyroid, perchlorate and thiocyanate do not inhibit iodine transport in breast tumors. The presence of iodinated proteins suggests the longer retention time. The unequivocal demonstration of NIS expression, its functionality and retention of iodine by organification further provides supportive evidence for use of radioiodine as an additional treatment modality of human breast carcinoma.
Similar content being viewed by others
References
Vieja ADL, Dohan O, Levy O, Carrasco N: Molecular analysis of the sodium/iodide symporter: Impact on thyroid and extrathyroidal pathophysiology. Physiol Rev 1083-1105, 2000
Strum JM: Site of iodination in rat mammary gland. Anat Rec 192: 235-244, 1978
Shah NM, Eskin BA, Krouse TB, Sparks CE: Iodoprotein formation by rat mammary glands during pregnancy and early postpartum period. P Soc Exp Biol Med 181: 443-449, 1986
Spitzweg C, Joba W, Eisennenger W, Heufelder AE: Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of it complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa. J Clin Endocr Metab 83: 1746-1751, 1998
Tazebay UH, Waenir IL, Levy O, Dohan O, Zuckier SJ, Zhao QH, Deng HF, Amenta PS, Fineberg S, Pestell R, Carrasco N: The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med 6: 871-878, 2000
Daniel GH, Haber DA: Will radioiodine be useful in treatment of breast cancer? Nature Med 6: 859-860, 2000
Nakamoto Y, Saga T, Misaki T, Koyabashi H, Sato N, Ishimori T, Kosugi S, Sakahara H, Konishi J: Establishment and characterization of a breast cancer cell line expressing Na+/I-symporter for radioiodine concentrator gene therapy. J Nucl Med 41: 1898-1904, 2000
Dadachova E, Bouzahzah B, Zuckier LS, Pestell RG: Rhenium-188 as an alternative to iodine-131 for treatment of breast tumors expressing the sodium iodide symporter (NIS). Nucl Med Biol 29: 13-18, 2002
Saito T, Endo T, Kawaguchi A, Ikeda M, Nakazato M, Kogai T, Onaya T: Increased expression of Na+/I-symporter in cultured human thyroid cells exposed to thyrotropin and in Graves' thyroid tissue. J Clin Endocr Metabol 82: 3331-3336, 1997
Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidine thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987
Sambrook J, Fritsch EF, Maniatis J: Molecular Cloning: A Laboratory Manual. 2nd edn. Cold Spring Harbor Laboratory, 1989
Castro MR, Elizabeth R, Bergert TG, Mciver BB, Goellner JR, Morris JC: Development of monoclonal antibodies against sodium iodide symporter: Immunohistochemical characterization of this protein in thyroid cells. J Clin Endocr Metabol 84: 2957-2962, 1999
Socolow EL, Ingbar SH: Metabolism of 99mpertechnetate by the thyroid gland of the rat. Endocrinology 80: 337-344, 1967
Rillema JM, Rowady DL: Characteristics of the prolactin stimulation of iodide uptake in to mouse mammary gland explants. P Soc Exp Biol Med 215: 366-369, 1997
Freinkel N, Ingbar SH: The metabolism of I131 by surviving slices of rat mammary tissue. Endocrinology 58: 51-56, 1956
Field JB, Larsen PR, Yamashita K, Mashiter K, Dekker A: Demonstration of iodide transport defect but normal iodide organification in nonfunctioning nodules of human thyroid glands. J Clin Invest 52: 2404-2410, 1973
Kogai T, Endo T, Saito T, Miyazaki A, Kawaguchi A, Onaya T: Regulation by thyroid stimulating hormone of sodium/iodide symporter gene expression and protein levels in FRTL-5 cells. Endocrinology 138: 2227-2232, 1997
Thomas-Morvan C, Nataf B, Tubiana M: In vivo and organ culture studies of thyroid proteins and hormone synthesis in human thyroid cancer tissues. Ann Radiol (Paris) 20: 739-742, 1977
Cancroft ET, Goldsmith SJ: 99m Tc-pertechnetate scintigraphy as an aid in the diagnosis of breast masses. Radiology 106: 441-444, 1973
Strum JM, Becci PJ: Analysis of mammary tumors for cytochemical evidence of endogeneous mammary peroxidase. Virchows Arch B 31: 135-142, 1979
Ray G, Batra S, Shukla NK, Deo S, Raina V, Anand S, Husain SA: Lipid peroxidation, free radical production and antioxidant status in breast cancer. Breast Cancer Res Treat 59: 163-170, 2000
Turk J, Henderson WR, Klebanoff SJ, Hubbard WC: Iodination of arachidonic acid mediated by eosinophil peroxidase, myeloperoxidase and lactoperoxidase. Identification and comparison of products. Biochim Biophys Acta 751: 189-200, 1983
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Upadhyay, G., Singh, R., Agarwal, G. et al. Functional Expression of Sodium Iodide Symporter (NIS) in Human Breast Cancer Tissue. Breast Cancer Res Treat 77, 157–165 (2003). https://doi.org/10.1023/A:1021321409159
Issue Date:
DOI: https://doi.org/10.1023/A:1021321409159